RTSN

NASD Retension Pharmaceuticals Inc

Nov 1, 2026 · 7:55 AM ET EOD Market Closed

$11.36 ↑ +0.00 (+0.00%) Trading Up from the previous close of $11.36, $0.40 below the day’s high of $11.76

YTD change: +7.88%
vs 20-day SMA: N/A
vs 200-day SMA: N/A

Price ranges

Previous day

$10.85 $11.76

open $11.76 close $11.36

-$0.40 (-3.40%)

Today

$10.85 $11.76

$11.36

Past week

$11.30 $16.29

from $15.50 now $11.36

-$4.14 (-26.71%)

Past month

$0.00 $10.53

from $10.53 now $11.36

+$0.83 (+7.88%)

This year

$9.66 $18.64

from $10.53 now $11.36

+$0.83 (+7.88%)

Price & Performance

+0.83 (+7.88%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A

The stock is 39.1% away from all-time highs of $18.64
RTSN is up 8% since the beginning of the year
RTSN is up 8% over the past 12 months
RTSN is up 8% over the past 1 month

RTSN reads n/a: the 12-month move is +7.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-0.5292

Earnings momentum N/A Quarterly EPS growth

Quarterly change N/A

Valuation

P/E ratio N/A

Enterprise value $107.9M

Balance sheet & scale

IncomeN/A

RevenueN/A

Cash$13.5M

Debt$28.2K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $94.6M

Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling, a key mechanism underlying the development and severity of hypertension. The company was founded by Eric Keller and Paul Sweetnam in 2023 and is headquartered in Falls Church, VA.

Competitor comparison

Ticker	Company	Price	Change
LLY	Eli Lilly and Company	$1,417.54	+3.19%
JNJ	Johnson & Johnson	$273.20	-0.73%
ABBV	AbbVie, Inc.	$294.89	+1.41%
MRK	Merck & Co., Inc.	$149.52	+2.18%
RHHBY	Roche Holding Ltd Sponsored ADR	$61.27	+0.82%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.